Discovery of pyrimidine-tethered benzothiazole derivatives as novel anti-tubercular agents towards multi- and extensively drug resistant Mycobacterium tuberculosis

References

• Sandhu GK. Tuberculosis: current situation, challenges and overview of its control programs in India. J Glob Infect Dis. 2011;3(2):143–150.
   PubMedGoogle Scholar
• Glaziou P, Floyd K, Raviglione MC. Global epidemiology of tuberculosis. Semin Respir Crit Care Med. 2018;39(3):271–285.
   PubMed Web of Science ®Google Scholar
• Chakaya J, Khan M, Ntoumi F, Aklillu E, Fatima R, Mwaba P, Kapata N, Mfinanga S, Hasnain SE, Katoto PDMC, et al. Global Tuberculosis Report 2020 – reflections on the global TB burden, treatment and prevention efforts. Int J Infect Dis. 2021;113(Suppl. 1):S7–S12. ‏
   PubMedGoogle Scholar
• Feuerriegel S, Oberhauser B, George AG, Dafae F, Richter E, Rüsch-Gerdes S, Niemann S. Sequence analysis for detection of first-line drug resistance in Mycobacterium tuberculosis strains from a high-incidence setting. BMC Microbiol. 2012;12(1):90.‏
   PubMedGoogle Scholar
• Montoro E, Lemus D, Echemendia M, Martin A, Portaels F, Palomino JC. Comparative evaluation of the nitrate reduction assay, the MTT test, and the resazurin microtitre assay for drug susceptibility testing of clinical isolates of Mycobacterium tuberculosis. J Antimicrob Chemother. 2005;55(4):500–505. ‏
   PubMed Web of Science ®Google Scholar
• Coninx R, Mathieu C, Debacker M, Mirzoev F, Ismaelov A, de Haller R, Meddings DR. First-line tuberculosis therapy and drug-resistant Mycobacterium tuberculosis in prisons. Lancet. 1999;353(9157):969–973.
   PubMed Web of Science ®Google Scholar
• Ferguson LA, Rhoads J. Multidrug-resistant and extensively drug-resistant tuberculosis: the new face of an old disease. J Am Acad Nurse Pract. 2009;21(11):603–609. ‏
   PubMedGoogle Scholar
• Tuyiringire N, Tusubira D, Munyampundu JP, Tolo CU, Muvunyi CM, Ogwang PE. Application of metabolomics to drug discovery and understanding the mechanisms of action of medicinal plants with anti-tuberculosis activity. Clin Transl Med. 2018;7:1–12.
   PubMed Web of Science ®Google Scholar
• Ribeiro ALdJL, Degiacomi G, Ewann F, Buroni S, Incandela ML, Chiarelli LR, Mori G, Kim J, Contreras-Dominguez M, Park Y-S, et al. Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis. PLOS One. 2011;6(11):e26675. ‏
   PubMed Web of Science ®Google Scholar
• Trefzer C, Škovierová H, Buroni S, Bobovská A, Nenci S, Molteni E, Pojer F, Pasca MR, Makarov V, Cole ST, et al. Benzothiazinones are suicide inhibitors of mycobacterial decaprenylphosphoryl-β-d-ribofuranose 2′-oxidase DprE1. J Am Chem Soc. 2012;134(2):912–915. ‏
   PubMed Web of Science ®Google Scholar
• Makarov V, Lechartier B, Zhang M, Neres J, van der Sar AM, Raadsen SA, Hartkoorn RC, Ryabova OB, Vocat A, Decosterd LA, et al. Towards a new combination therapy for tuberculosis with next generation benzothiazinones. EMBO Mol Med. 2014;6(3):372–383. ‏
   PubMed Web of Science ®Google Scholar
• De La Sierra IL, Munier-Lehmann H, Gilles AM, Bârzu O, Delarue M. X-ray structure of TMP kinase from Mycobacterium tuberculosis complexed with TMP at 1.95 Å resolution. J Mol Biol. 2001;311(1):87–100.
   PubMed Web of Science ®Google Scholar
• Vanheusden V, Munier-Lehmann H, Pochet S, Herdewijn P, Van Calenbergh S. Synthesis and evaluation of thymidine-5′-O-monophosphate analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase. Bioorg Med Chem Lett. 2002;12(19):2695–2698.
   PubMed Web of Science ®Google Scholar
• Munier-Lehmann H, Chenal-Francisque V, Ionescu M, Chrisova P, Foulon J, Carniel E, Bârzu O. Relationship between bacterial virulence and nucleotide metabolism: a mutation in the adenylate kinase gene renders Yersinia pestis avirulent. Biochem J. 2003;373(Pt 2):515–522. ‏
   PubMedGoogle Scholar
• Gjorgjieva M, Tomašič T, Kikelj D, Mašič LP. Benzothiazole-based compounds in antibacterial drug discovery. Curr Med Chem. 2018;25(38):5218–5236. ‏
   PubMed Web of Science ®Google Scholar
• Rouf A, Tanyeli C. Bioactive thiazole and benzothiazole derivatives. Eur J Med Chem. 2015;97:911–927. ‏
   PubMed Web of Science ®Google Scholar
• Gill RK, Rawal RK, Bariwal J. Recent advances in the chemistry and biology of benzothiazoles. Arch Pharm. 2015;348(3):155–178. ‏
   PubMed Web of Science ®Google Scholar
• Dar AA, Shadab M, Khan S, Ali N, Khan AT. One-pot synthesis and evaluation of antileishmanial activities of functionalized S-alkyl/aryl benzothiazole-2-carbothioate scaffold. J Org Chem. 2016;81(8):3149–3160. ‏
   PubMed Web of Science ®Google Scholar
• Shaikh FM, Patel NB, Sanna G, Busonera B, La Colla P, Rajani DP. Synthesis of some new 2-amino-6-thiocyanato benzothiazole derivatives bearing 2,4-thiazolidinediones and screening of their in vitro antimicrobial, antitubercular and antiviral activities. Med Chem Res. 2015;24(8):3129–3142. ‏
   Web of Science ®Google Scholar
• Mikulášek S, Odlerová Ž, Sutoris V, Perjessy A, Solčániová E. Benzothiazole compounds. XIII. Synthesis and antitubercular activity of some N-[1-(6-R-2-benzothiazolylamino)-2,2,2-trichloroethyl] formamide,-acetamide,-chloroacetamide, and-benzamide derivatives. Chem Pap. 1978;32:691–700. ‏
   Google Scholar
• Landge S, Mullick AB, Nagalapur K, Neres J, Subbulakshmi V, Murugan K, Ghosh A, Sadler C, Fellows MD, Humnabadkar V, et al. Discovery of benzothiazoles as antimycobacterial agents: synthesis, structure–activity relationships and binding studies with Mycobacterium tuberculosis decaprenylphosphoryl-β-d-ribose 2′-oxidase. Bioorg Med Chem. 2015;23(24):7694–7710.
   PubMed Web of Science ®Google Scholar
• Patel RV, Patel PK, Kumari P, Rajani DP, Chikhalia KH. Synthesis of benzimidazolyl-1,3,4-oxadiazol-2ylthio-N-phenyl (benzothiazolyl) acetamides as antibacterial, antifungal and antituberculosis agents. Eur J Med Chem. 2012;53:41–51. ‏
   PubMed Web of Science ®Google Scholar
• Chikhale RV, Bhole RP, Khedekar PB, Bhusari KP. Synthesis and pharmacological investigation of 3-(substituted 1-phenylethanone)-4-(substituted phenyl)-1,2,3,4-tetrahydropyrimidine-5-carboxylates. Eur J Med Chem. 2009;44(9):3645–3653. ‏
   PubMed Web of Science ®Google Scholar
• Gawad J, Bonde C. Design, synthesis and biological evaluation of some 2-(6-nitrobenzo [d] thiazol-2-ylthio)-N-benzyl-N-(6-nitrobenzo [d] thiazol-2-yl) acetamide derivatives as selective DprE1 inhibitors. Synth Commun. 2019;49(20):2696–2708. ‏
   Web of Science ®Google Scholar
• Mohamed MS, Awad SM, Sayed AI. Synthesis of certain pyrimidine derivatives as antimicrobial agents and anti-inflammatory agents. Molecules. 2010;15(3):1882–1890.
   PubMed Web of Science ®Google Scholar
• Patil SB. Biological and medicinal significance of pyrimidines: a review. Int J Pharm Sci Res. 2018;9:44–52.
   Web of Science ®Google Scholar
• Kamalakannan P, Venkappayya D. Synthesis and characterization of cobalt and nickel chelates of 5-dimethylaminomethyl-2-thiouracil and their evaluation as antimicrobial and anticancer agents. J Inorg Biochem. 2002;90(1–2):22–37.
   PubMed Web of Science ®Google Scholar
• Ding Y, Girardet JL, Smith KL, Larson G, Prigaro B, Wu JZ, Yao N. Parallel synthesis of 5-cyano-6-aryl-2-thiouracil derivatives as inhibitors for hepatitis C viral NS5B-dependent RNA polymerase. Bioorg Chem. 2006;34(1):26–38.
   PubMed Web of Science ®Google Scholar
• Kittakoop P, Mahidol C, Ruchirawat S. Alkaloids as important scaffolds in therapeutic drugs for the treatments of cancer, tuberculosis, and smoking cessation. Curr Top Med Chem. 2014;14(2):239–252.
   PubMed Web of Science ®Google Scholar
• Mahran AM, Hassan NA, Osman DA, Ragab SS, Hassan AA. Synthesis and biological evaluation of novel pyrimidines derived from 6-aryl-5-cyano-2-thiouracil. Z Naturforsch C J Biosci. 2016;71(5–6):133–140.
   PubMed Web of Science ®Google Scholar
• Pisal MM, Nawale LU, Patil MD, Bhansali SG, Gajbhiye JM, Sarkar D, Chavan SP, Borate HB. Hybrids of thienopyrimidinones and thiouracils as anti-tubercular agents: SAR and docking studies. Eur J Med Chem. 2017;127:459–469.
   PubMed Web of Science ®Google Scholar
• Chitre TS, Bothara KG, Patil SM, Asgaonkar KD, Nagappa S, Kathiravan MK. Design, synthesis, docking and anti-mycobacterial activity of some novel thiouracil derivatives as thymidine monophoshate kinase (TMPKmt) inhibitors. Int J Res Pharm Biomed Sci. 2011;2:616–623. ‏
   Google Scholar
• Mdluli K, Spigelman M. Novel targets for tuberculosis drug discovery. Curr Opin Pharmacol. 2006;6(5):459–467. ‏
   PubMed Web of Science ®Google Scholar
• Husseiny EM. Synthesis, cytotoxicity of some pyrazoles and pyrazolo [1,5-a] pyrimidines bearing benzothiazole moiety and investigation of their mechanism of action. Bioorg Chem. 2020;102:104053.
   PubMed Web of Science ®Google Scholar
• Bondock S, Fadaly W, Metwally MA. Enaminonitrile in heterocyclic synthesis: synthesis and antimicrobial evaluation of some new pyrazole, isoxazole and pyrimidine derivatives incorporating a benzothiazole moiety. Eur J Med Chem. 2009;44(12):4813–4818. ‏
   PubMed Web of Science ®Google Scholar
• Keri RS, Keri RS, Patil MR, Patil SA, Budagumpi S. A comprehensive review in current developments of benzothiazole-based molecules in medicinal chemistry. Eur J Med Chem. 2015;89:207–251. ‏
   PubMed Web of Science ®Google Scholar
• Doma A, Kulkarni R, Garlapati A, Radha P. Synthesis and anti-inflammatory activity of novel pyrimidino benzothiazole amine derivatives. Pharmacophore. 2014;5:331–342.
   Google Scholar
• Azam MA, Dharanya L, Mehta CC, Sachdeva S. Synthesis and biological evaluation of some novel pyrazolopyrimidines incorporating a benzothiazole ring system. Acta Pharm. 2013;63(1):19–30.
   PubMed Web of Science ®Google Scholar
• Diao PC, Lin WY, Jian XE, Li YH, You WW, Zhao PL. Discovery of novel pyrimidine-based benzothiazole derivatives as potent cyclin-dependent kinase 2 inhibitors with anticancer activity. Eur J Med Chem. 2019;179:196–207.
   PubMed Web of Science ®Google Scholar
• Chikhale R, Menghani S, Babu R, Bansode R, Bhargavi G, Karodia N, Rajasekharan MV, Paradkar A, Khedekar P. Development of selective DprE1 inhibitors: design, synthesis, crystal structure and antitubercular activity of benzothiazolylpyrimidine-5-carboxamides. Eur J Med Chem. 2015;96:30–46. ‏
   PubMed Web of Science ®Google Scholar
• Bhoi MN, Borad MA, Jethava DJ, Acharya PT, Pithawala EA, Patel CN, Pandya HA, Patel HD. Synthesis, biological evaluation and computational study of novel isoniazid containing 4H-pyrimido [2,1-b] benzothiazoles derivatives. Eur J Med Chem. 2019;177:12–31.
   PubMed Web of Science ®Google Scholar
• Patel RV, Kumari P, Rajani DP, Chikhalia KH. Synthesis of coumarin-based 1,3,4-oxadiazol-2ylthio-N-phenyl/benzothiazolyl acetamides as antimicrobial and antituberculosis agents. Med Chem Res. 2013;22(1):195–210.
   Web of Science ®Google Scholar
• Ramesh B, Bhalgat CM. Novel dihydropyrimidines and its pyrazole derivatives: synthesis and pharmacological screening. Eur J Med Chem. 2011;46(5):1882–1891. ‏
   PubMed Web of Science ®Google Scholar
• Ram VJ. Chemotherapeutic agents, XVIII: synthesis of π-deficient pyrimidines and fused pyrimidines as leishmanicidal agents. Arch Pharm. 1990;323(11):895–899. ‏
   PubMed Web of Science ®Google Scholar
• Hassan GS, Awdallah FM, El-Saadi MT, Elgendi AO, Hemeda LR. Synthesis of some benzothiazole derivatives evaluated as antimicrobials and antibiofilms. J Chem Pharm. 2015;7:1125–1143.‏
   Google Scholar
• Hassan NW, Saudi MN, Abdel-Ghany YS, Ismail A, Elzahhar PA, Sriram D, Nassra R, Abdel-Aziz MM, El-Hawash SA. Novel pyrazine based anti-tubercular agents: design, synthesis, biological evaluation and in silico studies. Bioorg Chem. 2020;96:103610.
   PubMed Web of Science ®Google Scholar
• Morris GM, Lim-Wilby M. Molecular docking. Methods Mol Biol. 2008;443:365–382.
   PubMedGoogle Scholar
• Wang F, Sambandan D, Halder R, Wang J, Batt SM, Weinrick B, Ahmad I, Yang P, Zhang Y, Kim J, et al. Identification of a small molecule with activity against drug-resistant and persistent tuberculosis. Proc Natl Acad Sci USA. 2013;110(27):E2510–E2517.
   PubMed Web of Science ®Google Scholar
• Fioravanti E, Adam V, Munier-Lehmann H, Bourgeois D. The crystal structure of Mycobacterium tuberculosis thymidylate kinase in complex with 3′-azidodeoxythymidine monophosphate suggests a mechanism for competitive inhibition. Biochemistry. 2005;44(1):130–137.
   PubMed Web of Science ®Google Scholar
• Eldehna WM, El Hassab MA, Abdelshafi NA, Al-Zahraa Sayed F, Fares M, Al-Rashood ST, Elsayed ZM, Abdel-Aziz MM, Elkaeed EB, Elsabahy M, et al. Development of potent nanosized isatin–isonicotinohydrazide hybrid for management of Mycobacterium tuberculosis. Int J Pharm. 2022;612:121369.
   PubMedGoogle Scholar
• (a) Elsayed ZM, Eldehna WM, Abdel-Aziz MM, El Hassab MA, Elkaeed EB, Al-Warhi T, Abdel-Aziz HA, Abou-Seri SM, Mohammed ER. Development of novel isatin–nicotinohydrazide hybrids with potent activity against susceptible/resistant Mycobacterium tuberculosis and bronchitis causing-bacteria. J Enzyme Inhib Med Chem. 2021;36(1):384–392.
   PubMed Web of Science ®Google Scholar
  (b) Al-Warhi T, Elimam DM, Elsayed ZM, Abdel-Aziz MM, Maklad RM, Al-Karmalawy AA, Afarinkia K, Abourehab MA, Abdel-Aziz HA, Eldehna WM. Development of novel isatin thiazolyl-pyrazoline hybrids as promising antimicrobials in MDR pathogens. RSC Adv. 2022;12(48):31466–31477.
   PubMed Web of Science ®Google Scholar
• Vilar S, Cozza G, Moro S. Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery. Curr Top Med Chem. 2008;8(18):1555–1572.
   PubMed Web of Science ®Google Scholar